# STEMLINE THERAPEUTICS INC

STEMLINE THERAPEUTICS INC is a company headquartered in New York, NY, United States.

## Company overview

- **Legal name:** STEMLINE THERAPEUTICS INC
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** New York, NY, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001264587

## About

STEMLINE THERAPEUTICS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001264587, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-03-16, it reported net income of USD -76,817,225; total assets of USD 186,979,004 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Net income:** -$76.8M (USD -76,817,225)
- **Total assets:** $187.0M (USD 186,979,004)
- **Cash and equivalents:** $13.6M (USD 13,561,712)
- **Operating cash flow:** -$67.7M (USD -67,689,973)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $500,000 (USD 500,000)
- **Net income:** -$85.0M (USD -85,024,365)
- **Total assets:** $63.5M (USD 63,493,570)
- **Cash and equivalents:** $9.4M (USD 9,443,667)
- **Operating cash flow:** -$72.2M (USD -72,181,918)

### FY2017 (period ended 2017-12-31)

- **Net income:** -$67.8M (USD -67,828,394)
- **Total assets:** $67.0M (USD 67,006,168)
- **Cash and equivalents:** $4.8M (USD 4,795,098)
- **Operating cash flow:** -$49.6M (USD -49,618,794)

## Recent SEC filings

- Form 8-K — filed 2020-06-10 — period 2020-06-10 — FORM 8-K
- Form SC 13D — filed 2020-05-13 — SC 13D
- Form 10-Q — filed 2020-05-11 — period 2020-03-31 — FORM 10-Q
- Form 8-K — filed 2020-05-04 — period 2020-05-04 — FORM 8-K
- Form DEF 14A — filed 2020-04-29 — period 2020-06-25 — DEF 14A
- Form 10-K — filed 2020-03-16 — period 2019-12-31 — FORM 10-K
- Form 8-K — filed 2020-03-13 — period 2020-03-13 — FORM 8-K
- Form SC 13G — filed 2020-02-14 — SCHEDULE 13G
- Form SC 13G — filed 2020-02-12 — SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP
- Form SC 13G — filed 2020-02-04 — SC 13G
- Form 10-Q — filed 2019-11-12 — period 2019-09-30 — 10-Q
- Form 8-K — filed 2019-11-07 — period 2019-11-07 — 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/stemline-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology